期刊文献+

白介素-4在博莱霉素致大鼠肺纤维模型中的表达 被引量:3

The expression of IL-4 in bleomycin-induced pulmonary fibrosis in rats
下载PDF
导出
摘要 目的检测IL-4在博莱霉素致大鼠肺纤维化模型中的表达,从而探讨IL-4在肺纤维化发病机制中的作用。方法体重170~190g的雌性wistar大鼠,立即气管内灌注博莱霉素5mg/(kg·bw)建立肺纤维化模型,设立生理盐水对照组。第7、14天分别处死大鼠,收获肺组织及血清,右肺行苏木精-伊红(HE)染色,左肺经逆转录-聚合酶链式反应(RT-PCR)检测肺组织中IL-4mRNA的表达,酶联免疫吸附实验(ELISA)检测血清中IL-4的水平。结果灌注博莱霉素后第7天肺组织病变以肺泡炎为主,第14天肺内有纤维化病灶形成。模型组大鼠IL-4mRNA相对表达强度和IL-4蛋白质水平明显高于对照组,差异有显著性(P<0.05)。结论在肺纤维化大鼠模型中IL-4的产生明显增高,IL-4在肺纤维化发病机制中具有重要作用。可将调节IL-4的产生及拮抗IL-4的作用作为肺纤维化治疗研究的新方向。 Objective:To detect the expression of IL-4 in bleomycin-induced pulmonary fibrosis in rats and to study the effect of IL-4 in pulmonary fibrosis pathogenesis.Methods:Female wistar rats (170~190g weight) were treated with bleomycin(5 mg/kg weight) by intratracheal perfusion on day 0 to induce pulmonary fibrosis,while the controlled animals were only injected with normal saline (NS).The rats were killed on day 7 and 14,and lung tissue and blood serum were collected.The right lung was stained with hematoxylin-eosin.Reverse transcription polymerase chain reaction (RT-PCR) was used to detect the expression of IL-4mRNA in the left lung and ELISA was used to detect the levels of IL-4 in blood serum.Results:Alveolus inflammation was observed on day 7 and fibrosis focus was found on day 14.Compared with controlled group,the expression levels of IL-4mRNA in lung tissue and the levels of IL-4 in blood serum were elevated significantly in model groups(P<0.05).Conclusion:IL-4 may play an important role in pathogenesis of pulmonary fibrosis,and possibly,the down-regulation of IL-4 level or antagonist of IL-4 could be taken as a new direction for studying the treatment of pulmonary fibrosis.
作者 汪涛 刘忠
出处 《重庆医科大学学报》 CAS CSCD 2005年第1期20-22,26,共4页 Journal of Chongqing Medical University
关键词 肺纤维化 博莱霉素 大鼠 IL-4 Pulmonary fibrosis Bleomycin Rats IL-4
  • 相关文献

参考文献3

二级参考文献38

  • 1戴令娟,侯杰,蔡后荣,王伟,张道中.川芎嗪当归治疗肺间质纤维化的实验研究[J].中华结核和呼吸杂志,1996,19(1):26-28. 被引量:86
  • 2Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol, 2001, 99:308 -319.
  • 3Lukacs NW, Hogaboam C, Chensue SW, et al. Type l/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest,2001, 120(1 Suppl) : 5S-8S.
  • 4Maeyama T, Kuwano K, Kawasaki M, et al. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am J Physiol Lung Cell Mol Physiol, 2001, 280:1128-1137.
  • 5Jaffe HA, Gao ZC, Moil Y, et al. Selective inhibition of collagen gene expression in fibroblasts by an interferon-3, transgene. Exp Lung Res, 1999, 25: 199-215.
  • 6Ziesche R, Hotbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1 b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med, 1999, 341 : 1264-1269.
  • 7Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic muse. Am Rev Respir Dis, 1979, 120: 893-899.
  • 8Keane MP, Belperio JA, Arenherg DA, et al. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol, 1999, 163 : 5686-5692.
  • 9Chen ES, Greenlee BM, Wills-Karp M, et al. Attenuation of lung inflammation and fibrosis in intederon-gamma-defieient mice after intratraeheal bleomyein. Am J Respir Cell Mol Biol, 2001,24 : 545-555.
  • 10Schrier DJ, Phan SH, McGarry BM. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis, 1983, 127 : 614-617.

共引文献45

同被引文献32

引证文献3

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部